PubMed

Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.

Regieli JJ, Jukema JW, Doevendans PA, Zwinderman AH, Kastelein JJ, Grobbee DE, van der Graaf Y.

J Am Coll Cardiol. 2009 Sep 29;54(14):1238-45.PMID: 19778663 [PubMed - indexed for MEDLINE]Related articles

PPAR gamma variant influences angiographic outcome and 10-year cardiovascular risk in male symptomatic coronary artery disease patients.

Regieli JJ, Jukema JW, Doevendans PA, Zwinderman AH, van der Graaf Y, Kastelein JJ, Grobbee DE.

Diabetes Care. 2009 May;32(5):839-44. Epub 2009 Feb 19.PMID: 19228871 [PubMed - indexed for MEDLINE]Related articlesFree article

CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.

Regieli JJ, Jukema JW, Grobbee DE, Kastelein JJ, Kuivenhoven JA, Zwinderman AH, van der Graaf Y, Bots ML, Doevendans PA.

Eur Heart J. 2008 Nov;29(22):2792-9. Epub 2008 Oct 28.PMID: 18957472 [PubMed - indexed for MEDLINE]Related articlesFree article

Inflammatory gene haplotype-interaction networks involved in coronary collateral formation.

Zhang J, Regieli JJ, Schipper M, Entius MM, Liang F, Koerselman J, Ruven HJ, van der Graaf Y, Grobbee DE, Doevendans PA.

Hum Hered. 2008;66(4):252-64. Epub 2008 Jul 9.PMID: 18612209 [PubMed - indexed for MEDLINE]Related articles

Coronary collaterals improve prognosis in patients with ischemic heart disease.

Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, van der Graaf Y, Doevendans PA.

Int J Cardiol. 2009 Feb 20;132(2):257-62. Epub 2008 Feb 1.PMID: 18242732 [PubMed - indexed for MEDLINE]Related articles

Coronary collaterals--insights in molecular determinants and prognostic relevance.

Regieli JJ, Nathoe HM, Koerselman J, van der Graaf Y, Grobbee DE, Doevendans PA.

Int J Cardiol. 2007 Mar 20;116(2):139-43. Epub 2006 Jul 10. Review.PMID: 16828902 [PubMed - indexed for MEDLINE]Related articles

Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.

Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE.

J Heart Lung Transplant. 2004 Mar;23(3):334-51.PMID: 15019644 [PubMed - indexed for MEDLINE]Related articles